In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The Calcutta High Court has sought a detailed report from the Central Security Agency on how the
Post 1 - Contender 6, whose claim is the strongest for the post of Chief Minister in Maharashtra?
Prime Minister Narendra Modi called for the formation of a Mahayuti government in Mumbai, but dur
The total debt of the central government increased by 2.15% to Rs 128.41 lakh crore in the Decemb
Elon Musk, the world's biggest rich, donated a total of 5,044,000 shares of his electric car comp
The Taliban, which is ruling Afghanistan, made an important announcement on Monday. According to
Politics has heated up since the incident of a BJP worker shamelessly urinating on tribal Dashmat
A shocking case has come to light in Kerala. Here a 17-year-old girl gave birth to a child at her
The death toll from the collapse of a 100-foot-tall hoarding in Mumbai's Ghatkopar due to the st
Rapid Rail: Rapid Rail going from Delhi to Meerut is one of the important projects of the governm
Reliance will open the country's first Jio drive-in theater in Mumbai on November 5. It will be o
